People News

CFO Thomas Dittrich To Exit Galderma

Dittrich will remain with the company in the same capacity through Q2 2026 until a permanent replacement is selected.

Galderma’s Chief Financial Officer Thomas Dittrich will exit the company after six years of service.

Dittrich plans to pursue another senior executive opportunity outside the organization. He will remain with the company in the same capacity through Q2 2026 until a permanent replacement is selected.

“We thank Thomas for his financial leadership and many contributions during his time at Galderma,” said Galderma CEO Flemming Ørnskov. “He played a key role in establishing the financial discipline, operational readiness, and strategic clarity that will continue to guide us forward. We wish him every success in his next role and remain focused on further accelerating Galderma’s strong growth – from category leadership to becoming a true powerhouse in dermatology.”

Dittrich thanked Flemming, the board of directors, investors and company colleagues for their support through an “impactful transformation” and career-related growth journey.

“I leave holding Galderma in the highest regard, enormously proud of the strides we’ve made together, and equally excited about Galderma’s continued growth momentum and long-term success,” he said.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters